Skip to main content
GenMont logo

GenMont — Investor Relations & Filings

Ticker · 3164 ISIN · TW0003164000 TW Manufacturing
Open in API
Filings indexed 1,617 across all filing types
Latest filing 2022-10-05 Director's Dealing
Country TW Taiwan
Listing TW 3164

About GenMont

www.genmont.com.tw

GenMont Biotech Inc. specializes in the research, development, and manufacturing of functional probiotics and postbiotics. The company operates advanced fermentation and production platforms for concentrated fermented milk, lactic acid bacteria powders, and functional microorganism strains. Its product portfolio features patented probiotic solutions targeting diverse health areas, including immune modulation, metabolic health, dental hygiene, digestive function, weight management, and pet wellness. Key proprietary strains include L. paracasei 33 and GMNL-32. GenMont leverages its technology platforms and extensive patent portfolio to deliver scientifically-backed health supplements. Beyond its proprietary brands, the company provides original equipment manufacturing (OEM) services, supporting the global market with high-quality probiotic and postbiotic ingredients certified by international standards.

Recent filings

Filing Released Lang Actions
111年09月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document is a detailed tabulation of shareholdings by insiders, including directors, their spouses, and minor children, as well as senior management and department heads. It lists share types, holdings at appointment, changes during the month, and current holdings. The document is focused on insider share transactions and holdings rather than financial results, management changes, or other corporate events. There is no indication of a full financial report, earnings release, or meeting materials. The content matches the definition of Director's Dealing, which reports personal share transactions by company directors and executives (insider trades). The document length is sufficient and contains substantive data on insider holdings and changes. Therefore, the appropriate classification is DIRS (Director's Dealing).
2022-10-05 Chinese
111年09月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings and pledged shares by company insiders, including directors and management, for a specific company (景岳生物科技股份有限公司). It lists share counts, pledged shares, and related percentages for various insiders. There is no indication of financial statements, earnings data, or report publication. The content focuses on insider shareholdings and pledges, which aligns with disclosures about insider transactions or holdings. This matches the definition of Director's Dealing (DIRS), which covers reports of personal share transactions or holdings by company directors and executives. The document length is 2375 characters, which is relatively short but contains detailed insider shareholding data, not just an announcement or certification. Therefore, the best classification is DIRS with high confidence.
2022-10-05 Chinese
111年8月背書保證與資金貸與
Capital/Financing Update Classification · 95% confidence The document is a brief financial disclosure from a listed company, 景岳, reporting on the status of fund loans and endorsement guarantees for the current and previous month, including cumulative amounts and limits. It contains no detailed financial statements or analysis, nor does it mention any report publication or regulatory certification. The content is a straightforward update on capital or financing-related information, specifically about loans and guarantees. Given the nature of the data and the absence of any other report type indicators, this fits best under Capital/Financing Update (CAP). The document length is short but contains substantive financial data related to capital activities, so it is not a mere announcement or certification.
2022-09-08 Chinese
111年8月營業收入
Regulatory Filings Classification · 95% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 景岳, presented in a tabular format with explanations about accounting standards and reporting practices. It contains no detailed financial statements, management discussion, or comprehensive analysis. The length is short (767 characters), and it appears to be a regulatory disclosure of financial data rather than a full report. There is no indication that this is an announcement of a report publication or a certification. The content fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement of financial data without the depth of an interim or annual report.
2022-09-08 Chinese
111年08月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document contains detailed tabular data about shareholdings of company insiders, including directors, their spouses, and minor children. It lists the number of shares held, changes in holdings, and other related information. The content is focused on insider share transactions and holdings rather than financial results, management changes, or other corporate events. There is no indication of it being a full financial report, earnings release, or management discussion. The document is not a brief announcement but a detailed disclosure of insider shareholdings. This matches the definition of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades). The document length is 9509 characters, sufficient for detailed disclosure. Therefore, the appropriate classification is DIRS.
2022-09-02 Chinese
111年08月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed disclosure of shareholdings and pledged shares by company insiders, including directors and management. It lists individual holdings, pledged shares, and related percentages. The content focuses on insider shareholdings and pledges rather than financial results, management changes, or meeting materials. This type of document corresponds to insider share transactions or holdings disclosures. Given the nature of the data, it fits best under Director's Dealing (DIRS), which covers reports of personal share transactions or holdings by company directors and executives. The document length is 2375 characters, which is consistent with a detailed insider shareholding report rather than a full financial report or announcement. Therefore, the classification is DIRS with high confidence.
2022-09-02 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.